13F manager/VIR/

Baillie Gifford exit Vir Biotechnology, Inc.

Baillie Gifford exit $-17.8M of disclosed value in Vir Biotechnology, Inc..

Signal
Investor Move
Action
Exit
Capital
$-17.8M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence